Canadian Cannabis Corp (CCAN) 0.7000 $CCAN Bedr
Post# of 273254
Posted On: 09/22/2016 1:19:11 AM
Canadian Cannabis Corp (CCAN) 0.7000 $CCAN
Bedrocan Canada and Canadian Cannabis Clinics Address Toronto Cannabis Patients
CNW Group - Tue May 24, 6:30AM CDT
Legal, regulated and affordable cannabis is easily accessible in Toronto, now with Same-day Delivery
CGC.VN: 3.840 (+0.250)
Jane CEO David Ellerstein to Speak at Canada's Premier Marijuana Business Conference
PRWeb - Tue May 10, 8:34AM CDT
Jane, the kiosk solution that helps cannabis retailers serve more customers and sell more product, announced that their chief executive officer, David Ellerstein, will be speaking on the financial services panel at the Canadian Cannabis Business Conference hosted by The Canadian Institute. The panel will take place Thursday, May 26, 2016 at 1:00pm ET at the Toronto Hilton in Toronto, Canada.
Canadian Cannabis Corp Joint Venture to Acquire 70% of Medicinal Cannabis Resource Centers Inc.
ACCESSWIRE - Fri Apr 29, 7:36AM CDT
OAKVILLE, ON / ACCESSWIRE / April 29, 2016 / Canadian Cannabis Corp. (OTCPK: CCAN) announces a joint venture between its wholly owned subsidiary, The Clinic Network (TCN) and Medicinal Cannabis Resource Centers Inc. (MCRCI).
Canadian Cannabis Corp. to Acquire Hydropothecary for $21.3 Million
Marketwired - Tue Oct 20, 7:00AM CDT
Canadian Cannabis Corp. (CCC) (OTC PINK: CCAN) plans to acquire Hydropothecary Corporation, a licensed producer of cannabis and cannabis oils and licensed distributor of Medicinal Marijuana under the Marijuana for Medical Purposes Regulations (MMPR - license link).
Tweed Looks to Control Nearly Half of Canadian Cannabis Market
ACCESSWIRE - Tue Sep 15, 8:20AM CDT
SEATTLE, WA / ACCESSWIRE / September 15, 2015 / The Canadian medical cannabis industry is expected to reach $1.3 billion in size by 2024, according to Health Canada, with over 400,000 patients joining over the next nine years. With about 16 licensed producers under the new MMPR program, the market has been heating up following the Canadian Supreme Court's ruling that cleared away at least some of the concerns related to the program and opened the door to wide-scale production and sales activity.
North America Cannabis Market: Focus on Application, Derivative, and Region - Estimation & Forecast, 2015-2020
M2 - Mon Sep 14, 10:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/n7wcc2/north_america) has announced the addition of the "North America Cannabis Market: Focus on Application, Derivative, and Region - Estimation & Forecast, 2015-2020" report to their offering. The North America Cannabis market is poised to grow from $ 3.46 billion in 2014 to $20.67 billion in 2020 at an estimated CAGR of 29.80% from 2015 to 2020. Factors like multifaceted applications of cannabis, expansion of licensing strategies, and automated irrigation system among others are driving this market towards growth. This market is also tackling some issues like volatile regulatory framework, absence of market leaders, perception towards marijuana, and environmental hazards among others. Owing to the fragmented supply chain and the presence of black market and perception issues, the cannabis market in North America has been estimated and forecasted strictly for the legal states, both for marijuana and hemp. The following pointers will encompass the scope of the research study and will lend a better understanding to the reader: - The total cannabis market is inclusive of the two primary derivatives namely-marijuana and Industrial Hemp - The market estimation for marijuana includes revenue from the legalized and active markets and Canada, where only medical marijuana is legalized - Certain states have legalized medical and recreational marijuana after 2013, however, there markets are not yet active and therefore, their market shares are not included in the total market size for the benchmark year (2014) - The report includes revenue for the marijuana market for all the active states having market share of above 0.5%. Rest of the state's revenue are clubbed as others - Through the forecast period, the other' states segment will also include the revenue from further states that are anticipated to legalize medical marijuana - The market size by application has been further segmented as applications of marijuana and industrial hemp for better clarity - The report includes the estimates of different entities of the cannabis ecosystem - The report also includes the optimistic revenue estimate for the benchmark year only for the U.S - Tax revenue estimate in case when marijuana is legalized across all the states in the U.S. has also been included Key Topics Covered: 1 Research Methodology, Scope And Coverage 2 Executive Summary 3 Introduction To North American Cannabis Market 4 Key Strategies And Development In The North American Cannabis Market (2013-2015) 5 Market Dynamics 6 North America Cannabis Industry Analysis 7 Regulatory & Legal Framework, Consortiums And Compliances 8 Market Sizing - Estimation, Analysis & Forecast By Derivative 9 Market Sizing- Estimation, Analysis & Forecast By Application 10 Market Sizing Analysis & Forecast, By Market Demand 11 Key Market Players Profiles - 22nd Century Group, Inc. - Abattis Bioceuticals Corporation - Advanced Cannabis Solutions - Affinor Growers - Agrisoft Development Group - Arena Pharmaceuticals, Inc. - Canadian Cannabis Corporation - Canna Brands Inc. - Canna Grow Holdings - Cannabics Pharmaceuticals Inc. - Cannabis Sativa Inc. - Cannabis Science, Inc. - Cannabis Therapy Corporation - Cannacare Docs - Cannavest - Dave - Eaze - Endexx Corporation - Equipment & Infrastructure - Frweed Pro - Grassp - Green Technology Solutions Inc. (Gtso) - Gw Pharmaceuticals - Hemp, Inc. - Information Technology - Insys Therapeutics - Leafly - Mass Roots - Meadow - Medbox, Inc. - Medical Marijuana Inc. - Nestdrop - Omnicanna Health Solutions - Otsuka Pharmaceutical Co. Ltd - Plandai Biotechnology - Privateer Holdings, Inc. - Quantum 9 - Sanofi Pharmaceuticals - Surna, Inc. - Tweed Marijuana Inc. - Weedmaps For more information visit http://www.researchandmarkets.com/research/n7...th_america
XXII: 1.25 (+0.04), INSY: 13.27 (-0.48), ARNA: 1.78 (+0.07)
4th Annual Gateway Conference to Showcase More Than 80 Growth Companies in San Francisco on September 9-10
Marketwired - Tue Jul 21, 7:31AM CDT
The 2015 Gateway Conference will showcase more than 80 public and private companies at the Four Seasons in San Francisco on September 9-10, 2015.
HEAR: 1.20 (+0.17), RGSE: 1.83 (-0.20), PRTS: 3.42 (+0.04), ANAD: 0.85 (unch), MATR: 4.04 (unch), AMRK: 16.20 (-0.37), BLDP: 2.07 (+0.08), ITI: 3.88 (+0.05), CSCD: 21.86 (-0.04), CPTA: 14.58 (+0.09), DTLK: 10.61 (+0.15), CRTN: 0.71 (+0.01), PFSW: 9.09 (+0.06), JVA: 5.41 (+0.04), MVIS: 1.39 (+0.01), PSG: 3.75 (+0.10), DMRC: 35.43 (+1.09), QBAK: 3.85 (+0.10), IDSY: 5.01 (-0.01), FARM: 35.02 (+0.22), OXBR: 5.00 (-0.07), WILN: 1.52 (unch), HTGC: 13.30 (+0.01), RGX.TO: 0.06 (unch), CVGW: 67.67 (-0.40), SNMX: 4.47 (unch), ABTL: 16.82 (+0.10), LINK: 10.00 (-0.15), BBSI: 47.87 (+0.27), SRT: 6.01 (+0.03), TTGT: 8.12 (-0.05), BUR: 2.34 (+0.02), GAIA: 7.65 (+0.07), TSYS: 4.99 (-0.02), LNDC: 12.78 (+0.26), HCI: 30.77 (+0.05), CALD: 17.93 (-0.11)
Aurora to Present at Canadian Cannabis Conference
Marketwired - Mon Jun 01, 1:07PM CDT
Aurora Cannabis Inc. (CSE: ACB)(FRANKFURT: 21P)(WKN: A1C4WM)(OTC PINK: PSNTF) ("Aurora" or the "Company) announces that on June 22, 2015, it will be presenting at the Inaugural Canadian Cannabis Conference presented by Jacob Securities.
Invictus MD Appoints Palu Phillips As President of VitaLeaf Management Inc.
TheNewswire.ca - Wed Apr 22, 7:30AM CDT
(via Thenewswire.ca)
Canadian Cannabis Corporation Expands Operations in Ontario-Set to Acquire Majority Stake in Hemisphere Pharmaceutical
Marketwired - Tue Mar 03, 7:31AM CST
Canadian Cannabis Corporation (OTCBB: CCAN) ("CCC"
today announced the execution of a Letter of Intent that provides for the acquisition of 60% of the outstanding shares in 8455562 Canada Inc. d/b/a Hemisphere Pharmaceutical ("HPI" based in Brantford, Ontario.
CORRECTION FROM SOURCE: Canadian Cannabis Corp. Appoints Richard Wachsberg as Independent Director
Marketwired - Thu Jan 15, 2:34PM CST
A correction from source is being issued for the Canadian Cannabis Corp. release that was disseminated on January 13, 2015 at 16:35 ET. In the first paragraph the year 2014 should have read as 2013. The corrected release follows:
NTRR Joint Venture Partner S2O2 Expands into Canadian Cannabis Industry with Plant-Boosting Antimicrobial Surface Treatments
BusinessWire - Thu Jan 15, 10:55AM CST
Neutra Corp. (OTCBB: NTRR) and joint venture partner Surface to Air Solutions (S2O2) expanded into the Canadian cannabis industry this week, announcing that they are now working with a licensed cannabis grower in Canada to demonstrate that their antimicrobial surface treatments can protect indoor crops by eliminating mold, fungus, germs, bacteria, allergens and pests.
Canadian Cannabis Corp. Appoints Richard Wachsberg as Independent Director
Marketwired - Tue Jan 13, 3:36PM CST
Canadian Cannabis Corp. ("CCAN" or the "Company" (OTCQB: CCAN) is pleased to announce the appointment of Mr. Richard Wachsberg to the Board of Directors. Richard is co-founder and Chairman of Apollo Health and Beauty Care, the leading Private Label and Control Label Personal Care Manufacturer in Canada with distribution throughout North and South America, Mexico, Europe, and Asia. Apollo Health and Beauty Care has been awarded the distinction of being one of Canada's 50 Best Managed Companies from 2003 to 2014 and has earned 50 Best Managed Company Platinum status since 2010.
Bedrocan Canada and Canadian Cannabis Clinics Address Toronto Cannabis Patients
CNW Group - Tue May 24, 6:30AM CDT
Legal, regulated and affordable cannabis is easily accessible in Toronto, now with Same-day Delivery
CGC.VN: 3.840 (+0.250)
Jane CEO David Ellerstein to Speak at Canada's Premier Marijuana Business Conference
PRWeb - Tue May 10, 8:34AM CDT
Jane, the kiosk solution that helps cannabis retailers serve more customers and sell more product, announced that their chief executive officer, David Ellerstein, will be speaking on the financial services panel at the Canadian Cannabis Business Conference hosted by The Canadian Institute. The panel will take place Thursday, May 26, 2016 at 1:00pm ET at the Toronto Hilton in Toronto, Canada.
Canadian Cannabis Corp Joint Venture to Acquire 70% of Medicinal Cannabis Resource Centers Inc.
ACCESSWIRE - Fri Apr 29, 7:36AM CDT
OAKVILLE, ON / ACCESSWIRE / April 29, 2016 / Canadian Cannabis Corp. (OTCPK: CCAN) announces a joint venture between its wholly owned subsidiary, The Clinic Network (TCN) and Medicinal Cannabis Resource Centers Inc. (MCRCI).
Canadian Cannabis Corp. to Acquire Hydropothecary for $21.3 Million
Marketwired - Tue Oct 20, 7:00AM CDT
Canadian Cannabis Corp. (CCC) (OTC PINK: CCAN) plans to acquire Hydropothecary Corporation, a licensed producer of cannabis and cannabis oils and licensed distributor of Medicinal Marijuana under the Marijuana for Medical Purposes Regulations (MMPR - license link).
Tweed Looks to Control Nearly Half of Canadian Cannabis Market
ACCESSWIRE - Tue Sep 15, 8:20AM CDT
SEATTLE, WA / ACCESSWIRE / September 15, 2015 / The Canadian medical cannabis industry is expected to reach $1.3 billion in size by 2024, according to Health Canada, with over 400,000 patients joining over the next nine years. With about 16 licensed producers under the new MMPR program, the market has been heating up following the Canadian Supreme Court's ruling that cleared away at least some of the concerns related to the program and opened the door to wide-scale production and sales activity.
North America Cannabis Market: Focus on Application, Derivative, and Region - Estimation & Forecast, 2015-2020
M2 - Mon Sep 14, 10:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/n7wcc2/north_america) has announced the addition of the "North America Cannabis Market: Focus on Application, Derivative, and Region - Estimation & Forecast, 2015-2020" report to their offering. The North America Cannabis market is poised to grow from $ 3.46 billion in 2014 to $20.67 billion in 2020 at an estimated CAGR of 29.80% from 2015 to 2020. Factors like multifaceted applications of cannabis, expansion of licensing strategies, and automated irrigation system among others are driving this market towards growth. This market is also tackling some issues like volatile regulatory framework, absence of market leaders, perception towards marijuana, and environmental hazards among others. Owing to the fragmented supply chain and the presence of black market and perception issues, the cannabis market in North America has been estimated and forecasted strictly for the legal states, both for marijuana and hemp. The following pointers will encompass the scope of the research study and will lend a better understanding to the reader: - The total cannabis market is inclusive of the two primary derivatives namely-marijuana and Industrial Hemp - The market estimation for marijuana includes revenue from the legalized and active markets and Canada, where only medical marijuana is legalized - Certain states have legalized medical and recreational marijuana after 2013, however, there markets are not yet active and therefore, their market shares are not included in the total market size for the benchmark year (2014) - The report includes revenue for the marijuana market for all the active states having market share of above 0.5%. Rest of the state's revenue are clubbed as others - Through the forecast period, the other' states segment will also include the revenue from further states that are anticipated to legalize medical marijuana - The market size by application has been further segmented as applications of marijuana and industrial hemp for better clarity - The report includes the estimates of different entities of the cannabis ecosystem - The report also includes the optimistic revenue estimate for the benchmark year only for the U.S - Tax revenue estimate in case when marijuana is legalized across all the states in the U.S. has also been included Key Topics Covered: 1 Research Methodology, Scope And Coverage 2 Executive Summary 3 Introduction To North American Cannabis Market 4 Key Strategies And Development In The North American Cannabis Market (2013-2015) 5 Market Dynamics 6 North America Cannabis Industry Analysis 7 Regulatory & Legal Framework, Consortiums And Compliances 8 Market Sizing - Estimation, Analysis & Forecast By Derivative 9 Market Sizing- Estimation, Analysis & Forecast By Application 10 Market Sizing Analysis & Forecast, By Market Demand 11 Key Market Players Profiles - 22nd Century Group, Inc. - Abattis Bioceuticals Corporation - Advanced Cannabis Solutions - Affinor Growers - Agrisoft Development Group - Arena Pharmaceuticals, Inc. - Canadian Cannabis Corporation - Canna Brands Inc. - Canna Grow Holdings - Cannabics Pharmaceuticals Inc. - Cannabis Sativa Inc. - Cannabis Science, Inc. - Cannabis Therapy Corporation - Cannacare Docs - Cannavest - Dave - Eaze - Endexx Corporation - Equipment & Infrastructure - Frweed Pro - Grassp - Green Technology Solutions Inc. (Gtso) - Gw Pharmaceuticals - Hemp, Inc. - Information Technology - Insys Therapeutics - Leafly - Mass Roots - Meadow - Medbox, Inc. - Medical Marijuana Inc. - Nestdrop - Omnicanna Health Solutions - Otsuka Pharmaceutical Co. Ltd - Plandai Biotechnology - Privateer Holdings, Inc. - Quantum 9 - Sanofi Pharmaceuticals - Surna, Inc. - Tweed Marijuana Inc. - Weedmaps For more information visit http://www.researchandmarkets.com/research/n7...th_america
XXII: 1.25 (+0.04), INSY: 13.27 (-0.48), ARNA: 1.78 (+0.07)
4th Annual Gateway Conference to Showcase More Than 80 Growth Companies in San Francisco on September 9-10
Marketwired - Tue Jul 21, 7:31AM CDT
The 2015 Gateway Conference will showcase more than 80 public and private companies at the Four Seasons in San Francisco on September 9-10, 2015.
HEAR: 1.20 (+0.17), RGSE: 1.83 (-0.20), PRTS: 3.42 (+0.04), ANAD: 0.85 (unch), MATR: 4.04 (unch), AMRK: 16.20 (-0.37), BLDP: 2.07 (+0.08), ITI: 3.88 (+0.05), CSCD: 21.86 (-0.04), CPTA: 14.58 (+0.09), DTLK: 10.61 (+0.15), CRTN: 0.71 (+0.01), PFSW: 9.09 (+0.06), JVA: 5.41 (+0.04), MVIS: 1.39 (+0.01), PSG: 3.75 (+0.10), DMRC: 35.43 (+1.09), QBAK: 3.85 (+0.10), IDSY: 5.01 (-0.01), FARM: 35.02 (+0.22), OXBR: 5.00 (-0.07), WILN: 1.52 (unch), HTGC: 13.30 (+0.01), RGX.TO: 0.06 (unch), CVGW: 67.67 (-0.40), SNMX: 4.47 (unch), ABTL: 16.82 (+0.10), LINK: 10.00 (-0.15), BBSI: 47.87 (+0.27), SRT: 6.01 (+0.03), TTGT: 8.12 (-0.05), BUR: 2.34 (+0.02), GAIA: 7.65 (+0.07), TSYS: 4.99 (-0.02), LNDC: 12.78 (+0.26), HCI: 30.77 (+0.05), CALD: 17.93 (-0.11)
Aurora to Present at Canadian Cannabis Conference
Marketwired - Mon Jun 01, 1:07PM CDT
Aurora Cannabis Inc. (CSE: ACB)(FRANKFURT: 21P)(WKN: A1C4WM)(OTC PINK: PSNTF) ("Aurora" or the "Company) announces that on June 22, 2015, it will be presenting at the Inaugural Canadian Cannabis Conference presented by Jacob Securities.
Invictus MD Appoints Palu Phillips As President of VitaLeaf Management Inc.
TheNewswire.ca - Wed Apr 22, 7:30AM CDT
(via Thenewswire.ca)
Canadian Cannabis Corporation Expands Operations in Ontario-Set to Acquire Majority Stake in Hemisphere Pharmaceutical
Marketwired - Tue Mar 03, 7:31AM CST
Canadian Cannabis Corporation (OTCBB: CCAN) ("CCC"
today announced the execution of a Letter of Intent that provides for the acquisition of 60% of the outstanding shares in 8455562 Canada Inc. d/b/a Hemisphere Pharmaceutical ("HPI" based in Brantford, Ontario. CORRECTION FROM SOURCE: Canadian Cannabis Corp. Appoints Richard Wachsberg as Independent Director
Marketwired - Thu Jan 15, 2:34PM CST
A correction from source is being issued for the Canadian Cannabis Corp. release that was disseminated on January 13, 2015 at 16:35 ET. In the first paragraph the year 2014 should have read as 2013. The corrected release follows:
NTRR Joint Venture Partner S2O2 Expands into Canadian Cannabis Industry with Plant-Boosting Antimicrobial Surface Treatments
BusinessWire - Thu Jan 15, 10:55AM CST
Neutra Corp. (OTCBB: NTRR) and joint venture partner Surface to Air Solutions (S2O2) expanded into the Canadian cannabis industry this week, announcing that they are now working with a licensed cannabis grower in Canada to demonstrate that their antimicrobial surface treatments can protect indoor crops by eliminating mold, fungus, germs, bacteria, allergens and pests.
Canadian Cannabis Corp. Appoints Richard Wachsberg as Independent Director
Marketwired - Tue Jan 13, 3:36PM CST
Canadian Cannabis Corp. ("CCAN" or the "Company"
(OTCQB: CCAN) is pleased to announce the appointment of Mr. Richard Wachsberg to the Board of Directors. Richard is co-founder and Chairman of Apollo Health and Beauty Care, the leading Private Label and Control Label Personal Care Manufacturer in Canada with distribution throughout North and South America, Mexico, Europe, and Asia. Apollo Health and Beauty Care has been awarded the distinction of being one of Canada's 50 Best Managed Companies from 2003 to 2014 and has earned 50 Best Managed Company Platinum status since 2010. 
(0)
(0)Scroll down for more posts ▼